LYOPHILISIERTE THROMBOZYTENLYSATE

European patent · EP2806885 · In force

Register entry

Publication number
EP2806885
Application number
EP13740649
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 28, 2013
Published
Dec 3, 2014
Granted
Sep 23, 2020
Protection ends at the latest
Jan 27, 2033
Next annual fee due
Jan 31, 2027
IPC classes
A61K 38/24 (2006.01)
A61K 35/14 (2015.01)
A61K 9/127 (2006.01)
A61K 9/48 (2006.01)
A61P 17/00 (2006.01)
A61L 27/36 (2006.01)
Priority
US 201213358797 26.01.2012
PCT application
PCT/US2013/023490 28.01.2013
PCT publication
WO2013/113024 01.08.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Oct 28, 2020

    Agent entered

    Representative
    Ammann Patentanwälte AG Bern, Schwarztorstrasse 31, 3001 Bern

    Published in Swissreg on 28.10.2020

  6. Sep 23, 2020

    Granted

    Published in Swissreg on 23.09.2020

Parties

Holder

Jadi Cell LLC

1040 Chartwell Ct., Salt Lake City, UT 84103, US

Agent

Ammann Patentanwälte AG

Ammann Patentanwälte AG Bern

Schwarztorstrasse 31, 3001 Bern

Inventor

PATEL, Amit

Salt Lake City, UT 84103, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.